Raffaele Renella

Attending Staff Physician & Head of Research Laboratory

Centre Hospitalier Universitaire Vaudois
Country flagSwitzerland

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Raffaele Renella is an Attending Staff Physician and Head of Research Laboratory at the Centre Hospitalier Universitaire Vaudois in Switzerland. His research areas include pediatric oncology, hematological malignancies, and genetic disorders, as evidenced by his recent studies on childhood cancers, chromatin profiling, and dietary impacts in early childhood. Dr. Renella's work investigates therapeutic vulnerabilities in various tumors and explores new treatment paradigms for complex conditions.

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Cell fate transitions observed in embryonic development involve changes in three-dimensional genomic organization that provide proper lineage specification. Whether similar events occur within tumor cells and contribute to cancer evolution remains largely unexplored. We modeled this process in the pediatric cancer Ewing sarcoma and investigated high-resolution looping and large-scale nuclear conformation changes associated with the oncogenic fusion protein EWS-FLI1. We show that chromatin interactions in tumor cells are dominated by highly connected looping hubs centered on EWS-FLI1 binding sites, which directly control the activity of linked enhancers and promoters to establish oncogenic expression programs. Conversely, EWS-FLI1 depletion led to the disassembly of these looping networks and a widespread nuclear reorganization through the establishment of new looping patterns and large-scale compartment configuration matching those observed in mesenchymal stem cells, a candidate Ewing sarcoma progenitor. Our data demonstrate that major architectural features of nuclear organization in cancer cells can depend on single oncogenes and are readily reversed to reestablish latent differentiation programs.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (15)

Fabio Candotti

Full Professor of Medicine

Lausanne University Hospital

SWITZERLAND
View details

Claire Mayor

senior lecturer

University of Geneva

SWITZERLAND
View details

Pierluigi Ballabeni

Centre for Primary Care and Public Health (Unisanté), University of Lausanne

SWITZERLAND
View details

Giulia Cossu

Lausanne University Hospital (CHUV)

SWITZERLAND
View details

Loïc Garçon

-

FRANCE
View details

Caroline Scott

Weatherall Institute of Molecular Medicine

UNITED KINGDOM
View details

Dominic Waithe

University of Oxford

UNITED KINGDOM
View details

Madeleine Verhovsek

-

CANADA
View details

Fabien Kuttler

EPFL (École Polytechnique Fédérale de Lausanne)

SWITZERLAND
View details

Roberto Papait

Associate professor

University of Insubria

ITALY
View details

Carlo Rivolta

Professor of Ophthalmic Genetics

University of Basel

SWITZERLAND
View details

Christopher John Newman

Lausanne University Hospital

SWITZERLAND
View details

Rémi Buisson

Associate Professor

University of California, Irvine

UNITED STATES
View details

Nicolò Riggi

Lausanne University Hospital

SWITZERLAND
View details

Jean-Luc Bulliard

Head of sector Epidemiology and Data Science & Scientific Director of Neuchâtel-Jura Cancer Registry

Centre for Primary Care and Public Health (Unisanté), University of Lausanne

SWITZERLAND
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.